More about Krishna Institute of Medical Sciences Limited
Fundamentals for Krishna Institute of Medical Sciences Limited
Regulatory Filings for Krishna Institute of Medical Sciences Limited
The Renewable Success Story Beyond Solar
Startups Mint India’s New Billionaires
India's Biggest IPO Has a Bigger Meaning
From Watches to Wealth: Titan's New Empire
Fundamentals for Krishna Institute of Medical Sciences Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, Alzheimer's, bone, joint center specialties, and others. In addition, the company provides medical procedures for aneurysm, ankle arthritis and total ankle replacement, anterior cervical discectomy and fusion surgery, anterior resection, aortic aneurysm, aortic stent graft, aortic valve replacement, arthroscopy, atrial septal defect, bariatric surgery, and others. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.
Revenue projections:
Investors are expected to be cautious with KIMS, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.
Financial Ratios:
| currentRatio | 0.757000 |
|---|---|
| forwardPE | 46.301617 |
| debtToEquity | 166.226000 |
| earningsGrowth | -0.583000 |
| revenueGrowth | 0.348000 |
| grossMargins | 0.592400 |
| operatingMargins | 0.115020 |
| trailingEps | 6.040000 |
| forwardEps | 17.148430 |
KIMS's elevated debt-to-equity ratio suggests the company is highly leveraged, meaning it has significant debt compared to equity. This can be risky, particularly if KIMS's cash flow or profits decrease, making it harder to meet debt obligations.
KIMS's low earnings and revenue growth suggest shrinking profits are likely. This could reflect broader financial struggles, signaling that the company might face difficulties in sustaining its profitability.
KIMS's negative gross and operating margins indicate that the company is not generating profit from either production or day-to-day operations. This could suggest cost overruns or declining revenue, impacting its financial stability.
KIMS's forward EPS is higher than its trailing EPS, suggesting the company is expected to see an increase in profitability this year. This points to positive growth, indicating that KIMS is projected to improve its financial performance compared to the previous year.
Price projections:
The price of KIMS has remained consistently close to the lower limit of projections. This ongoing pattern raises concerns about the stock's performance and may reflect market hesitance regarding the company's growth prospects.
Recommendation changes over time:
Analysts' buy bias for KIMS signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to KIMS, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
SEBI's New Gateway Is Rewiring Foreign Investment in India
Why Japan Backs India’s Truckers
India's $69B Eurasian Trade Power Play